UChicago Cancer
LightNews LightNews
banner
uchicagocancer.bsky.social
UChicago Cancer
@uchicagocancer.bsky.social
240 followers 98 following 200 posts
Joint account for the NCI-designated UChicago Medicine Comprehensive Cancer Center and the University of Chicago's Section of Hematology/Oncology.

At the forefront of clinical care, research, and education. https://www.uchicagomedicine.org/cancer
Posts Replies Media Videos
uchicagocancer.bsky.social
🔥Hot off the press: In a new study, UChicago Cancer researchers show that restoring YTHDF2 function prevents normal skin cells from turning cancerous after excessive sun exposure. #UVRadiation #SkinCancer #Inflammation Nature Communications
https://www.nature.com/articles/s41467-025-64898-7
November 12, 2025 at 6:45 PM
uchicagocancer.bsky.social
In a recent interview with OncLive, Wendy Stock, MD, discussed the growing role of TKIs in Ph-positive ALL, the impact of molecular monitoring on treatment optimization to maximize efficacy and safety/quality of life.
https://ow.ly/OyAG50Xq7zU
November 11, 2025 at 6:13 PM
uchicagocancer.bsky.social
Dr. @fredhow.bsky.social and colleagues from across the globe have a new article out in @aacrjournals.bsky.social's Clinical Cancer Research: aacrjournals.org/clincancerre...

Read on to learn how they've used machine learning to better predict recurrence risk and treatment efficacy!
Machine Learning–Based Prediction of Distant Recurrence Risk and Ribociclib Treatment Effect in HR+/HER2– Early Breast Cancer Using Real-World and NATALEE Data
Abstract. Purpose: Despite current standard-of-care endocrine therapy, distant recurrence remains a concern for patients with HR+/HER2− early breast cancer (EBC). Understanding individual recurrence r...
aacrjournals.org
November 11, 2025 at 3:39 PM
Reposted by UChicago Cancer
cancerletter.com
“For someone like myself, I don’t think Yale would’ve paid $100,000 to get me an H-1B visa at the time, and I’m sure it’s going to be hard." - Kunle Odunsi (@uchicagocancer.bsky.social)
https://cancerletter.com/podcastc/20251107_1/
The Directors: Ruben Mesa and Kunle Odunsi on how immigration and diversity accelerate discovery “This has always made our environment stronger, not weaker.” - The Cancer Letter
At a time when federal immigration policies are becoming stricter, Kunle Odunsi, director of University of Chicago Medicine Comprehensive Cancer Center, reflected on the fact that cancer research is a highly international community. “Iwas born in Nigeria, I grew up in Nigeria, I went to medical school in Nigeria, and then I did some of […]
cancerletter.com
November 10, 2025 at 3:30 PM
uchicagocancer.bsky.social
🎙️In the latest episode of The Director, Drs. Odunsi and Mesa emphasize that diversity, international collaboration, and continuous funding support are essential to bring transformative cancer therapies to clinics. Ruben A. Mesa, MD, FACP The Cancer Letter
https://ow.ly/Z8NR50XpG05
November 10, 2025 at 9:36 PM
uchicagocancer.bsky.social
📕New in Journal of Experimental Medicine: Chen et al., show that radiotherapy may promote metastasis by upregulating YTHDF2 in dendritic cells, impairing MHC-1 cross presentation and CD8+ T cell activation.
Ludwig Cancer Research
https://ow.ly/BAeq50Xown3
November 7, 2025 at 5:42 PM
uchicagocancer.bsky.social
Researcher at the University of Chicago have developed a modular "plug-and-play" immune cell design that could make cancer immunotherapy treatments faster, smarter, and more adaptable.
#Immunotherapy #CART #NovelCancerTreatments
Read full story: https://ow.ly/mhpU50XnnNi
November 5, 2025 at 8:53 PM
uchicagocancer.bsky.social
Check out the inspiring story of Crystal Hendricks-Kretzer — a breast cancer survivor who benefited from a clinical trial that offered personalized breast cancer treatment using a novel antibody-drug conjugate. #BreastCancer #ClinicalTrials
https://ow.ly/46Zu50XmMAm
November 5, 2025 at 8:24 PM
uchicagocancer.bsky.social
UChicago's Post-ASH registration is open!! Coming up on January 30th, it will be a great overview of the highlights of this year's ASH! Find more at www.chicagopostash.com
Post ASH Annual Meeting - Hematology
University of Chicago Post ASH Annual Meeting - American Society of Hematology
www.chicagopostash.com
November 5, 2025 at 6:12 PM
uchicagocancer.bsky.social
Check out the inspiring story of Crystal Hendricks-Kretzer — a breast cancer survivor who benefited from a clinical trial that offered personalized breast cancer treatment using a novel antibody-drug conjugate. #BreastCancer #ClinicalTrials @UCh
https://ow.ly/46Zu50XmMAm
November 4, 2025 at 8:48 PM
uchicagocancer.bsky.social
A new article on alternative dosing strategies for oral cancer meds is out now from Drs. Wesevich & Ratain! You can find it at: www.sciencedirect.com/science/arti...

#AtTheForefront #MedicationDosing #CancerTreatment #OncSky
Potential alternative dosage strategies for patent-protected oral cancer drugs
To identify potential alternative dosage strategies for patent-protected oral oncology drugs that could reduce costs without decreasing efficacy for f…
www.sciencedirect.com
October 31, 2025 at 5:31 PM
uchicagocancer.bsky.social
We were delighted to honor Monica Bertagnolli, MD, former @NIH and the NCI director, with the 2025 Simon M. Shubitz Prize for her leadership in oncology and commitment to advancing equitable cancer care.
UChicagoBSD
@uchicagomedicine.bsky.social
https://ow.ly/vppj50XjTLY
October 30, 2025 at 4:26 PM
uchicagocancer.bsky.social
We were delighted to honor Monica Bertagnolli, MD, former @NIH and the NCI director, with the 2025 Simon M. Shubitz Prize for her leadership in oncology and commitment to advancing equitable cancer care.
UChicagoBSD @uchicagomedicine.bsky.social
https://ow.ly/vppj50XjTLY
Former NIH director Monica Bertagnolli awarded the 2025 Simon M. Shubitz Cancer Prize
Bertagnolli, a renowned surgical oncologist and physician-scientist, was honored for her research on the role of genetics and inflammation in the development of cancer and her leadership in oncology clinical research.
ow.ly
October 29, 2025 at 10:04 PM
uchicagocancer.bsky.social
We're excited to share that our cancer program has been named a Top 100 Oncology Program by Beckers Hospital Review!! SO proud of the incredible clinicians, researchers, and other team members who make this work possible every day!

www.beckershospitalreview.com/oncology/100...
100 hospitals and health systems with great oncology progra…
Becker’s Healthcare is proud to unveil its 2025 list of hospitals and health systems recognized for excellence in oncology. These leading institutions…
www.beckershospitalreview.com
October 29, 2025 at 4:09 PM
uchicagocancer.bsky.social
Congrats to Thomas Gajewski, MD, PhD, on the 2025 AACI Distinguished Scientist Award recognizing his pioneering research in tumor immunology and immunotherapy.
UChicagoBSD
University of Chicago Pathology
@uchicagomedicine.bsky.social
https://ow.ly/JMey50Xh2oA
October 29, 2025 at 3:47 PM
uchicagocancer.bsky.social
A recent study in Nature Cell Biology demonstrates that two microbial metabolites act in opposite ways on cell growth. Notably, pre-queuosine 1 inhibits cell proliferation, offering potential for the development of novel cancer therapies. @UChicagoBSD
https://ow.ly/5xS350Xjgab
October 28, 2025 at 5:53 PM
uchicagocancer.bsky.social
Join us for the 2025 Simon M. Shubitz Cancer Prize & Lectureship featuring Monica Bertagnolli, MD, a renowned surgical oncologist and physician-scientist, and former director of the National Institutes of Health.
#HarvardKennedySchool
📅October 27
⏰12 PM CST
Room: KCBD 1103
October 27, 2025 at 4:32 PM
uchicagocancer.bsky.social
Kathleen Humphries hadn’t had a mammogram in over 10 years when a screening at UChicago Medicine revealed stage 2 breast cancer. Thanks to early detection, expert care and the support of lifelong friends, Kathleen is on the path to recovery.
https://ow.ly/EIn450Xisgr
October 27, 2025 at 3:57 PM
uchicagocancer.bsky.social
A recent study found that #FearofCancerRecurrence was higher among breast cancer patients diagnosed at younger ages, those experiencing stress, recurrent disease, or ER‐positive cancer, highlighting the need for psychosocial support in survivorship care. ow.ly/giAw50XhaZ5
October 23, 2025 at 8:46 PM
uchicagocancer.bsky.social
Congrats to Thomas Gajewski, MD, PhD, on the 2025 AACI Distinguished Scientist Award recognizing his pioneering research tumor immunology and immunotherapy.
ow.ly/JMey50Xh2oA
October 23, 2025 at 5:57 PM
Reposted by UChicago Cancer
genesndiseases.bsky.social
New review explores how #GPER contributes to #Endocrine resistance in HR+ #BreastCancer via genetic, #Epigenetic & microenvironmental changes, and its potential as a future #therapeutic target. @uchicagocancer.bsky.social #medsky‬ ‬‬

#OpenAccess: www.sciencedirect.com/science/arti...
October 21, 2025 at 1:35 PM
uchicagocancer.bsky.social
Starting the week off right by sharing a great new article in Therapeutic Advances in Medical Oncology from many of our oncology team members, including Drs. @fredhow.bsky.social, Pearson, Torcasso, Trujillo, Giger, and Fellow Dr. Matossian! Read it at
journals.sagepub.com/doi/10.1177/...
Virtual multiplex immunofluorescence identifies lymphocyte subsets predictive of response to neoadjuvant therapy - Anran Li, Madeleine Torcasso, Anna Woodard, Hanna Hieromnimon, Jonathan Trujillo, Lon...
Background: Hematoxylin and eosin (H&E) staining is routine in pathology but lacks cellular specificity. Multiplex immunofluorescence (mIF) captures spatial...
journals.sagepub.com
October 20, 2025 at 6:04 PM
uchicagocancer.bsky.social
UChicago Medicine Comprehensive Cancer Center is partnering with the #AmericanCancerSociety on an upcoming #MakingStridesAgainstBreastCancer event in Downtown Chicago. Join the forces by supporting the nation’s largest and most impactful breast cancer movement. @acscan.bsky.social
October 17, 2025 at 6:14 PM
uchicagocancer.bsky.social
The University of Chicago Medicine has launched BIOPSY NOW, a new initiative that provides same-day breast and lymph node biopsies for patients with imaging results highly suspicious for breast cancer. This means faster diagnosis, and if necessary, a head start on treatment.
ow.ly/vhCE50XcEnl
Same-day biopsy for highly suspicious breast cancer available through new UChicago Medicine initiative, BIOPSY NOW - UChicago Medicine
BIOPSY NOW, a new initiative launched by the University of Chicago Medicine, provides same-day breast and lymph node biopsies for patients whose mammograms and ultrasounds suggest a very high likeliho...
ow.ly
October 16, 2025 at 5:35 PM
uchicagocancer.bsky.social
A new study published in @gimjournal.bsky.social suggests addressing health literacy gaps about polygenic risk scores may help support informed decision-making among breast cancer patients from racial/ethnic minority backgrounds.
ow.ly/UaXt50XbZ3g
October 15, 2025 at 6:53 PM